MiMedx filed to initiate an Investigational New Drug Phase III clinical study comparing AmnioFix® Injectable to saline placebo in the treatment of Achilles Tendonitis.
SurGenTec was issued a U.S. patent protecting its Graftgun® bone graft loading technology used to post-fill all types of implantable cages in situ, including expandable designs.